FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-10.27%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$1.83B
AUM Growth
+$1.83B
(-21%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Quanterix
QTRX
|
$61.7M |
| 2 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$2.76M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $936M | 51.21% | 58,807,379 | – | – |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $301M | 16.45% | 38,296,526 | – | – |
|
|
KLDO
3
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $131M | 7.15% | 17,360,710 | – | – |
|
4
Denali Therapeutics
DNLI
$2.23B
| $123M | 6.71% | 8,005,747 | – | – |
|
|
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $111M | 6.08% | 18,233,403 | – | – |
|
6
Seres Therapeutics
MCRB
$166M
| $86.5M | 4.73% | 21,571,764 | – | – |
|
7
Transmedics
TMDX
$3.92B
| $60.1M | 3.29% | 2,530,275 | – | – |
|
|
AXLA
8
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $49.5M | 2.71% | 8,748,414 | – | – |
|
|
SYRS
9
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $30.5M | 1.67% | 2,938,494 -265,943 | -8% | -$2.76M |
|
|
10
Quanterix
QTRX
$211M
| – | – | -1,825,412 | Closed | -$61.7M |
|